Biomea Fusion, Inc. (BMEA)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Biomea Fusion, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Biomea Fusion, Inc. (BMEA) has returned 23.39% so far this year and -28.17% over the past 12 months.

Based on dividend-adjusted daily data since Apr 16, 2021, BMEA's average daily return is +0.04%, while the average monthly return is +0.71%. At this rate, your investment would double in approximately 8.2 years.

Historically, 42% of months were positive and 58% were negative. The best month was Mar 2023 with a return of +141.5%, while the worst month was Jun 2024 at -57.2%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 5 months.

On a daily basis, BMEA closed higher 47% of trading days. The best single day was Mar 28, 2023 with a return of +99.0%, while the worst single day was Jun 7, 2024 at -63.3%.

Biomea Fusion, Inc. has an annualized alpha of -2.55%, beta of 1.09, and R² of 0.03 versus S&P 500 Index. Calculated based on daily prices since April 19, 2021.

• This stock participated in 154.44% of S&P 500 Index downside but only -49.06% of its upside — more exposed to losses than it benefited from rallies.
• R² of 0.03 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

BMEA ranks 32 for risk / return — below 32% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The table below present risk-adjusted performance metrics for Biomea Fusion, Inc. (BMEA) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Biomea Fusion, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Biomea Fusion, Inc. was 97.71%, occurring on Dec 2, 2025. The portfolio has not yet recovered.

The current Biomea Fusion, Inc. drawdown is 96.34%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Biomea Fusion, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Biomea Fusion, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.